By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction (Revised, 4.0)
Overview
This guideline describes the critical decision points in the management of Dyslipidemia (LIPIDS) and provides clear and comprehensive evidence based recommendations.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: June 1, 2020
Contact: practice@apta.org
Content Type: CPG
Dyslipidemia Guideline Working Group; Department of Veterans Affairs, Department of Defense
You Might Also Like...
CPG
ESC/ERS 2022 Guidelines for the Diagnosis and Treatment of Pulmonary HypertensionOct 7, 2022
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory
CPG
Canadian Cardiovascular Society 2021 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultMar 26, 2021
Contains updated findings and recommendations including the use of non-fasting lipid determination as a suitable alternative to fasting levels.
CPG
Acute Coronary Syndromes [NICE NG185]Nov 18, 2020
Recommendations on how to improve survival and quality of life for people who have a heart attack or unstable angina.